Stockreport

Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data to FDA

Viveve Medical, Inc.  (VIVE) 
Last viveve medical, inc. earnings: 11/7 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: viveve.com
PDF      No serious adverse events reported in the submission                          Final study results could support a marketing application for expanded U.S. indication [Read more]